Ifp Advisors, Inc Biocryst Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 53 shares of BCRX stock, worth $479. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$479

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$7.03 - $8.43 $372 - $446	53 New	53 $0
Q2 2023 Aug 04, 2023	SELL	$6.96 - $8.81 $6 - $8	-1 Reduced 3.85%	25 $0
Q1 2023 Apr 18, 2023	SELL	$7.94 - $11.84 $43,804 - $65,321	-5,517 Reduced 99.53%	26 $0
Q4 2022 Feb 07, 2023	SELL	$10.5 - $14.2 $2,184 - $2,953	-208 Reduced 3.62%	5,543 $35,000
Q2 2022 Sep 06, 2022	BUY	$7.89 - $17.88 $45,375 - $102,827	5,751 New	5,751 $36,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $45,375 - $102,827	-5,751 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$11.56 - $19.76 $65,579 - $112,098	5,673 Added 7273.08%	5,751 $93,000
Q4 2021 Jan 12, 2022	SELL	$11.18 - $15.46 $5,142 - $7,111	-460 Reduced 85.5%	78 $1,000
Q3 2021 Oct 06, 2021	SELL	$14.21 - $17.65 $117,715 - $146,212	-8,284 Reduced 93.9%	538 $7,000
Q2 2021 Jul 13, 2021	BUY	$9.5 - $17.24 $25,868 - $46,944	2,723 Added 44.65%	8,822 $140,000
Q1 2021 Apr 30, 2021	SELL	$7.37 - $13.61 $8,814 - $16,277	-1,196 Reduced 16.39%	6,099 $63,000
Q4 2020 Jan 25, 2021	BUY	$3.37 - $8.61 $17,170 - $43,867	5,095 Added 231.59%	7,295 $55,000
Q3 2020 Oct 29, 2020	BUY	$3.43 - $5.53 $7,546 - $12,166	2,200 New	2,200 $7,000
Q2 2020 Aug 05, 2020	BUY	$1.9 - $5.61 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.6 - $4.11 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$1.59 - $3.45 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$2.5 - $3.73 $0 - $0	0 New	0 $0
Q4 2017 Jan 24, 2018	SELL	$4.16 - $5.33 $4,160 - $5,330	-1,000 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	1,000	1,000 $3,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

169M

Call Options Held

930K

Put Options Held

1.03M

Vanguard Group Inc Valley Forge, PA

21.9M
Shares

$198 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$181 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$107 Million
1.3% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$82.2 Million
4.33% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

8.14M
Shares

$73.7 Million
1.52% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.68B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account